Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,753,741,742
+$491,616,629 QoQ
Shares Held
41,283,933
-3.7% QoQ
Ownership
3.33%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.42623199199552.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5737680080044699.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital World Investors holds $43,445,551,682 across 10 Drug Manufacturers - General names. GILD ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,621,813 | $14,368,474,943 | |
| 2 | AMGN |
Amgen Inc
|
29,288,343 | $10,305,103,484 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
41,283,933 | $5,753,741,742 | |
| 4 | AZN |
Astrazeneca PLC
|
28,264,580 | $5,574,340,467 | |
| 5 | ABBV |
AbbVie Inc.
|
15,841,367 | $3,445,338,908 | |
| 6 | JNJ |
Johnson & Johnson
|
11,749,361 | $2,872,013,802 | |
| 7 | PFE |
Pfizer Inc
|
21,947,486 | $616,285,406 | |
| 8 | NVO |
Novo Nordisk A S
|
5,209,427 | $191,446,442 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,753,741,742 | 41,283,933 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,262,125,113 | 42,872,129 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,014,972,341 | 45,179,931 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,133,646,760 | 46,303,299 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,000,042,307 | 53,547,901 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,623,516,657 | 71,706,362 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,417,862,123 | 76,548,928 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,231,500,081 | 76,249,819 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,189,434,843 | 84,497,404 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,753,327,604 | 83,364,123 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,124,200,741 | 81,721,387 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,237,222,384 | 80,929,316 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,347,224,912 | 76,500,240 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,914,461,646 | 68,892,972 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,563,383,677 | 57,762,744 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,267,243,717 | 52,859,468 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,942,885,101 | 49,501,852 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $3,099,112,718 | 42,681,624 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,582,795,183 | 36,976,309 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,478,087,888 | 35,987,335 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,267,446,217 | 35,083,494 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,245,025,096 | 38,534,588 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,486,049,352 | 39,342,449 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,347,184,680 | 43,503,830 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,463,729,333 | 46,331,318 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||